The trade group argues CMS exceeded its authority with GLOBE, a Medicare Part B model tying drug rebates to prices in 19 other countries.
News|Articles|November 1, 2001
PEG-Intron (Peginterferon alfa-2b powder for injection) Schering
Combination use with ribavirin for chronic hepatitis C
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Ophthalmology coverage hinges on knowing the payer | AAO 2026
2
Experts urge earlier JAK inhibitor use in AD and vitiligo | Fall Clinical Derm 2026
3
A conversation about the cycle of ADHD and sleep problems in children, with Alison Pritchard, Ph.D.
4
Payer type drives wide variation in glaucoma surgery prices | AAO 2026
5